Home010600 • KRX
add
WellBiotec Co Ltd
Previous close
₩545.00
Year range
₩519.00 - ₩1,570.00
Market cap
49.55B KRW
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(KRW) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 23.06B | -8.54% |
Operating expense | 2.98B | -44.38% |
Net income | -5.42B | -136.27% |
Net profit margin | -23.51 | -158.35% |
Earnings per share | — | — |
EBITDA | 307.80M | 116.65% |
Effective tax rate | -2.46% | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.22B | -75.62% |
Total assets | 39.54B | -58.12% |
Total liabilities | 11.20B | -59.51% |
Total equity | 28.34B | — |
Shares outstanding | 90.36M | — |
Price to book | 1.74 | — |
Return on assets | 0.38% | — |
Return on capital | 0.49% | — |
Cash Flow
Net change in cash
(KRW) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -5.42B | -136.27% |
Cash from operations | 2.72B | 121.11% |
Cash from investing | 4.26B | 31.59% |
Cash from financing | -1.16B | -107.73% |
Net change in cash | 5.71B | 6.21% |
Free cash flow | 3.97B | 130.84% |
About
Founded
1975
Website
Employees
24